BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/12/2014 11:15:00 AM | Browse: 1420 | Download: 1692
 |
Received |
|
2014-06-25 09:11 |
 |
Peer-Review Started |
|
2014-06-27 08:43 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2014-09-16 15:03 |
 |
Revised |
|
2014-09-22 00:00 |
 |
Publication Fee Transferred |
|
|
 |
Second Decision by Editor |
|
2014-10-10 18:01 |
 |
Second Decision by Editor-in-Chief |
|
|
 |
Final Decision by Editorial Office Director |
|
2014-10-10 18:13 |
 |
Articles in Press |
|
2014-10-10 18:13 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2014-11-28 17:52 |
 |
Publish the Manuscript Online |
|
2014-12-12 11:14 |
| Category |
Transplantation |
| Manuscript Type |
Therapeutics Advances |
| Article Title |
Perspective of antiviral therapeutics for hepatitis C after liver transplantation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Cheng-Maw Ho, Rey-Heng Hu and Po-Huang Lee |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Cheng-Maw Ho, MD, Department of Surgery, National Taiwan University Hospital, 7 Chun-Shan S Rd, Taipei 100, Taiwan. miningho@ntu.edu.tw |
| Key Words |
Hepatitis C; Recurrence; Liver transplantation; Therapeutics; Fibrosis |
| Core Tip |
Management of hepatitis C virus (HCV) recurrence after liver transplantation used to be a bothering issue due mostly to the interferon-based therapy. Current available data from treatment of chronic HCV infection shows promising results of interferon-free, or even ribavirin-free, pan-genotypic, all oral medications will soon reform the treatment of HCV recurrence after liver transplantation. |
| Publish Date |
2014-12-12 11:14 |
| Citation |
Ho CM, Hu RH, Lee PH. Perspective of antiviral therapeutics for hepatitis C after liver transplantation. World J Pharmacol 2014; 3(4): 193-198
|
| URL |
http://www.wjgnet.com/2220-3192/full/v3/i4/193.htm |
| DOI |
http://dx.doi.org/10.5497/wjp.v3.i4.193 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.